C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2001
12/20/2001	CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/20/2001	CA2410229A1 Vaccine for congenital tremors in pigs
12/20/2001	CA2409315A1 Protein phosphatases
12/19/2001	EP1164196A1 Retroviral vectors
12/19/2001	EP1164189A1 Method for cloning and producing the RsaI restriction endonuclease in E.coli
12/19/2001	EP1163844A1 Transgenic mollusc and method for constructing the same
12/19/2001	EP1163517A2 Method of screening candidate compounds for susceptibility to biliary excretion
12/19/2001	EP1163515A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
12/19/2001	EP1163514A1 AN $i(IN VIVO) AND $i(IN VITRO) MODEL FOR CUTANEOUS PHOTOAGING AND OXIDATIVE DAMAGE
12/19/2001	EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001	EP1163354A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses
12/19/2001	EP1163353A2 Maize ku80 homolog and uses thereof
12/19/2001	EP1163352A1 Transgenic plants that are resistant to a broad spectrum of pathogens
12/19/2001	EP1163351A1 Chimeric promoters based on the plastocyanin pete promoter from pea
12/19/2001	EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof
12/19/2001	EP1163341A2 Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
12/19/2001	EP1163340A1 Compositions and methods for the modification of gene expression
12/19/2001	EP1163338A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS
12/19/2001	EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001	EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
12/19/2001	EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells
12/19/2001	EP1163332A1 48 human secreted proteins
12/19/2001	EP1163331A1 50 human secreted proteins
12/19/2001	EP1163327A1 Human protein kinase b gamma polypeptides and a method for disrupting protein kinase b gamma in a non-human
12/19/2001	EP1163326A1 Methods of microencapsulating pancreatic islet cells
12/19/2001	EP1163324A2 Genetically modified plants having modulated brassinosteroid signaling
12/19/2001	EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
12/19/2001	EP1163269A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR
12/19/2001	EP1163267A1 47 human secreted proteins
12/19/2001	EP1163266A2 Barley gene for thioredoxin and nadp-thioredoxin reductase
12/19/2001	EP1163260A1 Process for partitioning of proteins
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163252A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/19/2001	EP1163103A2 Surface and its manufacture and uses
12/19/2001	EP1163018A2 Mineralization and cellular patterning on biomaterial surfaces
12/19/2001	EP1162989A1 Use of dictyotal extracts in the production of a topical composition
12/19/2001	EP1162875A2 Plants transformed with thioredoxin
12/19/2001	EP0985029B1 Hyaluronic acid derivative based cell culture matrix and biodegradable three-dimensional matrix
12/19/2001	EP0858510B1 Process for preparing o-acetylserine, l-cysteine and l-cysteine-related products
12/19/2001	EP0758387B1 Thymidine kinase mutants
12/19/2001	EP0726942B1 Monoclonal antibodies to foam cells and their pharmaceutical and diagnostic use
12/19/2001	EP0535021B1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome
12/19/2001	EP0493581B1 Recombinant gene coding for a protein having an endochitinase activity
12/19/2001	EP0437488B2 Animal model for human disease
12/19/2001	CN1327480A Enhanced protein production in higher plants by N-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide
12/19/2001	CN1327476A Cleaning compositions comprising multily-substituted protease variants and amylase variants
12/19/2001	CN1327452A Fibroblast growth factor with hepatocyte proliferation activity
12/19/2001	CN1327388A Modified antibodies of induced anti-idiotype reaction enhancement
12/19/2001	CN1327050A Large scale cultivating inoculation method of animal cell stacking bed
12/19/2001	CN1326942A New polypeptide-CREB conjugated protein 30.8 and polynucleotide for encoding such polypeptide
12/19/2001	CN1076204C Recombinant coccidiosis vaccines
12/18/2001	US6331665 Insect resistant fertile transgenic corn plants
12/18/2001	US6331659 Cumulus cells as nuclear donors
12/18/2001	US6331621 Nucleotide sequences coding protein with enzymatic activity; for use in treatment of glomeronephritis, fibrosis, cirrhosis, cancer and arthritis
12/18/2001	US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
12/18/2001	US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration
12/18/2001	US6331612 Bone morphogenic protein-16 (BMP-16) compositions
12/18/2001	US6331527 Promoter smooth muscle cell expression
12/18/2001	US6331526 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides
12/18/2001	US6331433 Human T cell leukemia cell line designated D1.1
12/18/2001	US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity
12/18/2001	US6331422 Enzyme-mediated modification of fibrin for tissue engineering
12/18/2001	US6331416 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
12/18/2001	US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein
12/18/2001	US6331411 TopA
12/18/2001	US6331406 Human enbryonic germ cell and methods of use
12/18/2001	US6331403 Use of mCRP to slow cell growth and to promote maturation of cells
12/18/2001	US6331399 For therapeutic, diagnostic, and research applications for the modulation of telomer reverse transcriptase expression
12/18/2001	US6331395 Prenatal diagnostic methods
12/18/2001	US6331319 Implanted to replace or support damaged, diseased tissues or to form cell culture growth substrate
12/18/2001	US6331301 Isolated dna sequences which encodes amino acid sequence in protein;
12/18/2001	CA2221745C Improved embryogenesis process for initiation and maturation
12/18/2001	CA2209298C Mpl ligand analogs
12/18/2001	CA2179281C Methods of identifying lymphocytes with mutator phenotypes
12/18/2001	CA2088661C Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases
12/13/2001	WO2001094952A2 Methods and compositions for modulating oxidized ldl transport
12/13/2001	WO2001094949A2 Soluble cd1 compositions and uses thereof
12/13/2001	WO2001094944A2 Artificial antigen presenting cells and methods of use thereof
12/13/2001	WO2001094617A2 Protein fragment complementation assay based on beta-lactamase
12/13/2001	WO2001094600A2 Promoters for regulated gene expression
12/13/2001	WO2001094598A2 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells
12/13/2001	WO2001094587A2 Extracellular messengers
12/13/2001	WO2001094581A1 Tumour suppressor and uses thereof
12/13/2001	WO2001094580A1 Novel g-protein coupled receptor
12/13/2001	WO2001094562A2 Cold sensitive mutant dna polymerases
12/13/2001	WO2001094556A1 Method for conditionally immortalising cells and protein constructs therefor
12/13/2001	WO2001094555A1 Method for obtaining characterised muscle-derived cell populations and uses
12/13/2001	WO2001094554A1 Method for the genetic reconstruction of human organs
12/13/2001	WO2001094553A1 Method of amplifying natural killer t cells
12/13/2001	WO2001094552A2 Mammalian gamete and embryo culture media supplement and method of using same
12/13/2001	WO2001094551A2 Genetically modified t-cells, method for producing them and use thereof
12/13/2001	WO2001094549A2 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway
12/13/2001	WO2001094548A2 Hy2 family of bilin reductases
12/13/2001	WO2001094547A2 Molecular delivery vehicle for delivery of selected compounds to targets
12/13/2001	WO2001094544A2 N.bstnbi nicking endonuclease and methods for using endonucleases in single-stranded displacement amplification
12/13/2001	WO2001094541A2 Human mesenchymal progenitor cell
12/13/2001	WO2001094420A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
12/13/2001	WO2001094415A2 Nuclear hormone receptor
12/13/2001	WO2001094414A2 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE
12/13/2001	WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation

1 ... 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 ... 1827